Colistimethate 2 MIU Injection

Colistimethate Sodium Injection 2 MIU
A Critical Solution Against Multidrug-Resistant Gram-Negative Infections

Colistimethate Sodium Injection 2 MIU is a high-potency, last-resort antibiotic designed to combat severe infections caused by multidrug-resistant (MDR) Gram-negative pathogens. As antimicrobial resistance continues to rise, Colistimethate remains a cornerstone therapy in intensive care and hospital settings.

Key Features:

• Broad-Spectrum Gram-Negative Coverage: Highly effective against Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae – even those resistant to carbapenems.

• High-Potency Dosage: Each 2 MIU vial offers a powerful dose for flexible, weight- and severity-based dosing strategies.

• Trusted in Critical Care: Frequently used in ICU settings for serious infections like VAP, sepsis, and complicated UTIs.

• Essential for Stewardship Programs: A valuable agent in preserving antibiotic efficacy and combating resistance.